A team of researchers led by Prof. Dr. Carola Hunte has succeeded in describing how the antimalarial drug atovaquone binds to its target protein. The scientists used x-ray crystallography to determine the three-dimensional structure of the protein with the active substance bound. The drug combination atovaquone-proguanil (Malarone) is a medication used worldwide for the prevention and treatment of malaria. The data and the resulting findings ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/TqzhgZ
No comments:
Post a Comment